Omada Health, Inc. OMDA
19.66
(0.06)
(0.30%)
as of 25 Sep
- Market cap
- $1.2B
- P/E
- 281×
Follow OMDA
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+6 more TTM periods Free account |
0.00% | 0.00% | 8.38% | 1.84% | |
| (18.90%) | (8.37%) | (4.16%) | 1.36% | ||
ROIC |
(79.39%) | (97.89%) | (23.37%) | (0.93%) | |
Return on Tangible Assets |
(14.12%) | (6.23%) | (3.01%) | 1.88% | |
Average Days of Receivables |
65.81 | 48.51 | 51.52 | 66.66 | |
Free Cash Flow per Share |
(0.26) | 0.34 | 0.28 | 0.29 | |
Free Cash Flow |
(15.07) | 12.42 | 16.40 | 17.13 | |
Capital Expenditures |
(5.45) | (5.83) | (6.14) | (6.55) | |
Piotroski F-Score |
1.00 | 1.00 | 1.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
(2.31%) | 4.04% | 5.05% | 4.99% | |
Accounts Receivable Turnover |
0.00 | 0.00 | 8.94 | 6.89 | |
Accounts Payable Turnover |
0.00 | 0.00 | 15.58 | 10.26 | |
Inventory Turnover |
0.00 | 0.00 | 26.82 | 25.97 | |
Average Days of Payables |
23.21 | 42.02 | 30.94 | 43.72 | |
Days of Inventory on Hand |
13.67 | 18.34 | 14.63 | 15.26 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
16.52% | 15.63% | 15.73% | 15.88% | |
Selling, General and Administrative Expense of Revenue |
57.26% | 54.66% | 53.48% | 52.46% | |
Share Based Compensation of Revenue |
4.95% | 4.98% | 5.05% | 5.53% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.35 | (1.43) | (3.58) | 5.50 | |
Depreciation/Fixed assets |
1.18 | 1.15 | 1.11 | 1.06 | |
Capex/Depreciation |
(0.61) | (0.64) | (0.65) | (0.68) | |
Revenue per Share |
3.99 | 7.10 | 4.81 | 5.19 | |
Operating CF per Share |
(0.17) | 0.50 | 0.38 | 0.40 | |
Capex per Share |
(0.09) | (0.16) | (0.10) | (0.11) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | |
Net Profit Margin |
(11.82%) | (4.91%) | (2.22%) | 1.39% |
Columns are period end dates